The Impact of Liver Disease Aetiology and the Stages of Hepatic Fibrosis on the Performance of Non-Invasive Fibrosis Biomarkers: An International Study of 2411 Cases
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/j.1365-2036.2011.04861.x
Full Text
Open PDFAbstract
Available in full text
Date
October 9, 2011
Authors
Publisher
Wiley